Concepedia

Chatal Jf

CJ

Statistics

Publications

10

Citations

435

H-Index

10

Active since

1984

Affiliations

Inserm(Current)

Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers

Nantes Université

Chatal Jf is an author at Inserm specializing in oncology, medicine, and radionuclide therapy.

Publications per year

1984–2015

10

Publications

10

Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.

Françoise Kraeber‐Bodéré, Stéphane Bardet, Cornelis A. Hoefnagel et al. · PubMed · 1999 · 105 citations

, , +17

Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.

Jacques Barbet, P Peltier, Stéphane Bardet et al. · PubMed · 1998 · 105 citations

, , +17

Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer.

Manuel Bardiès, Stéphane Bardet, Alain Faivre-Chauvet et al. · PubMed · 1996 · 55 citations

, , +16

Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.

Françoise Kraeber‐Bodéré, A Faibre-Chauvet, Catherine Saï-Maurel et al. · PubMed · 1999 · 40 citations

, , +17

Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.

Gabriel Ricolleau, Chatal Jf, P. Fumoleau et al. · PubMed · 1984 · 39 citations

, , +16

1–5 of 10